[go: up one dir, main page]

NZ613090A - Modified release benzimidazole formulations - Google Patents

Modified release benzimidazole formulations

Info

Publication number
NZ613090A
NZ613090A NZ613090A NZ61309011A NZ613090A NZ 613090 A NZ613090 A NZ 613090A NZ 613090 A NZ613090 A NZ 613090A NZ 61309011 A NZ61309011 A NZ 61309011A NZ 613090 A NZ613090 A NZ 613090A
Authority
NZ
New Zealand
Prior art keywords
modified release
omeprazole
benzimidazole
methacrylic acid
ethyl acrylate
Prior art date
Application number
NZ613090A
Inventor
Lingam Meka
Srinivasa Almareddy Reddy
Vagisha Sinha
Hitesh Jogia
Srinivas Arutla
Raviraj Pillai
Rahul Sudhakar Gawande
Prasad Vure
Venkateswarlu Vobalaboina
Original Assignee
Reddy’S Lab Inc Dr
Reddy’S Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy’S Lab Inc Dr, Reddy’S Lab Ltd Dr filed Critical Reddy’S Lab Inc Dr
Publication of NZ613090A publication Critical patent/NZ613090A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Provided are oral modified release formulations comprising at least one benzimidazole compound. A preferred compound is the proton pump inhibitor omeprazole. In a preferred embodiment the formulation comprises particles containing omeprazole and having a polymer coating comprising methacrylic acid-ethyl acrylate copolymer, and particles containing omeprazole and having a release controlling polymer coating comprising methacrylic acid-ethyl acrylate copolymer and ammonio methacrylate copolymer.
NZ613090A 2010-12-29 2011-12-29 Modified release benzimidazole formulations NZ613090A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN4013CH2010 2010-12-29
US201161447759P 2011-03-01 2011-03-01
PCT/US2011/067868 WO2012092486A2 (en) 2010-12-29 2011-12-29 Modified release benzimidazole formulations

Publications (1)

Publication Number Publication Date
NZ613090A true NZ613090A (en) 2015-11-27

Family

ID=46383862

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ613090A NZ613090A (en) 2010-12-29 2011-12-29 Modified release benzimidazole formulations

Country Status (7)

Country Link
EP (1) EP2661260A4 (en)
CN (1) CN103402501A (en)
AU (1) AU2011352037A1 (en)
EA (1) EA201390979A1 (en)
NZ (1) NZ613090A (en)
UA (1) UA112855C2 (en)
WO (1) WO2012092486A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2851327C (en) * 2011-11-02 2019-06-25 Laboratorios Del Dr. Esteve, S.A. Coated pellets of omeprazole
JP6208261B2 (en) 2013-02-05 2017-10-04 パーデュー、ファーマ、リミテッド、パートナーシップＰｕｒｄｕｅ Ｐｈａｒｍａ Ｌ．Ｐ． Tampering resistant pharmaceutical preparation
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
WO2014142938A1 (en) * 2013-03-15 2014-09-18 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN112336696B (en) * 2020-12-01 2022-08-05 苏州中化药品工业有限公司 Long-acting pulse preparation and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050244497A1 (en) * 1997-11-05 2005-11-03 Wockhardt Limited Delayed delivery system for acid-sensitive drugs
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
JP4541807B2 (en) * 2004-09-03 2010-09-08 Ｏｋｉセミコンダクタ株式会社 Semiconductor element holding device and semiconductor element transport method
AR051654A1 (en) * 2004-11-04 2007-01-31 Astrazeneca Ab NEW FORMULATIONS OF MODIFIED RELEASE PELLETS FOR PROTON PUMP INHIBITORS
FR2891459B1 (en) * 2005-09-30 2007-12-28 Flamel Technologies Sa MICROPARTICLES WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE INGREDIENT AND ORAL GALENIC FORM COMPRISING THE SAME
JP2010534721A (en) * 2007-07-27 2010-11-11 ディポメド，インコーポレイティド Pulse type gastric retentive preparation
US20090214599A1 (en) * 2008-02-21 2009-08-27 Agi Therapeutics Plc Proton pump inhibitor formulations, and methods of preparing and using such formulations

Also Published As

Publication number Publication date
WO2012092486A2 (en) 2012-07-05
UA112855C2 (en) 2016-11-10
AU2011352037A1 (en) 2013-08-01
EP2661260A4 (en) 2014-05-14
EA201390979A1 (en) 2013-12-30
EP2661260A2 (en) 2013-11-13
CN103402501A (en) 2013-11-20
WO2012092486A3 (en) 2012-11-01

Similar Documents

Publication Publication Date Title
NZ613090A (en) Modified release benzimidazole formulations
ECSP13012718A (en) ORAL DISINTEGRATION COMPRESSED
WO2010027676A3 (en) Dental composition comprising biphenyl di(meth)acrylate monomer
EP2351761A4 (en) Novel metal complex, and method for producing -olefin polymer and method for producing -olefin/(meth)acrylate copolymer each using the metal complex
MX2019013171A (en) Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof.
EP2226339A4 (en) (meth)acrylic acid/alkyl (meth)acrylate ester copolymer and cosmetic preparation containing the same
HRP20171022T1 (en) Combination of an oxidant and a photoactivator for the healing of wounds
PH12012502442A1 (en) Solid compositions
MY155242A (en) Antireflective coating compositions
MX338413B (en) Tooth film formulations.
GB2459393B (en) Novel capsule formulation for the proton pump inhibitor omeprazole
KR100744835B9 (en) Phosphate-based acrylate crosslinking agent for polymer electrolyte and polymer electrolyte composition containing same
EP2178549A4 (en) ANTIMICROBIAL PEPTIDE, COMPOSITIONS AND METHODS OF USE
NZ603881A (en) High refractive index, acrylic ophthalmic device materials with reduced glistenings
ZA200703112B (en) New modified release pellet formulations for proton pump inhibitors
BRPI0918614A2 (en) (meth) acrylate monomer, polymer and coating agent
WO2012080833A3 (en) Controlled release dosage forms
PH12015501127A1 (en) Abrasive coatings for peroxide-coantaining compositions
EP2403935A4 (en) COMPOSITIONS COMPRISING ANGIOGENIC FACTORS AND METHODS OF USE
EP2042523A4 (en) Crosslinked (meth)acrylic acid copolymer and secondary-cell electrode employing the same
JP2014520171A5 (en)
TN2011000261A1 (en) Octreotide depot formulation with constantly high exposure levels
EP2554555A4 (en) Adamantyl (meth)acrylate monomer and (meth)acrylic polymer that contains repeating units derived from the monomer
MX2013010729A (en) Structural adhesives, process for the preparation thereof, and application thereof.
WO2008145475A8 (en) Oral care composition

Legal Events

Date Code Title Description
PSEA Patent sealed
LAPS Patent lapsed